Page 7 - Solid Biosciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Solid Biosciences […]

Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.

Shares of Solid Biosciences Inc. (SLDB) are up 27% on Wednesday following the announcement of FDA clearance of its Investigational New Drug (IND) application for SGT-003, which is the company's latest gene therapy candidate for Duchenne Muscular Dystrophy (Duchenne).

Shares of CorMedix Inc. (NASDAQ: CRMD) surged in pre-market trading as the company posted a narrower-than-expected third-quarter loss. Cormedix posted a loss of 17 cents per share for the third quarter, versus market expectations for a loss of 21 cents per share.

Accord Financial 3Q Loss/Shr C$1.03; 3Q Rev C$19.4M; 3Q Adj Loss/Shr C$0.97 Almonty Industries 3Q Rev C$4.45M; 3Q Loss/Shr C$0.01 Canaccord Genuity 2Q Rev C$337.3M, Down 11% on Year; 2Q... -November 15, 2023 at 06:14 am EST - MarketScreener